Jan Stenvang

CTO Scandion Oncology at Scandion Oncology - N/A, N/A, DK

Jan Stenvang's Colleagues at Scandion Oncology
Jane Hinrichsen

Medical Laboratory Technician

Contact Jane Hinrichsen

Maj Hedtjärn

COO and Head of R&D Operations

Contact Maj Hedtjärn

Johnny Stilou

Acting CEO & Chief Financial Officer

Contact Johnny Stilou

Peter Vestlev

Distinguished Medical Scientist

Contact Peter Vestlev

View All Jan Stenvang's Colleagues
Jan Stenvang's Contact Details
HQ
N/A
Location
Copenhagen,Capital Region of Denmark,Denmark
Company
Scandion Oncology
Jan Stenvang's Company Details
Scandion Oncology logo, Scandion Oncology contact details

Scandion Oncology

N/A, N/A, DK • 5 - 9 Employees
BioTech/Drugs

Scandion Oncology A/S is a listed Danish biotechnology company with the mission to address one of the most important challenges in modern oncology - the effective treatment of cancer which has developed resistance towards existing cancer medicine. The company's first-in-class lead compound, SCO-101, is an add-on to chemotherapy and is currently in clinical phase I and II studies in cancer patients. The company also has several preclinical programs to build a broader pipeline of drugs for the treatment of drug resistant cancer diseases.

N/A
Details about Scandion Oncology
Frequently Asked Questions about Jan Stenvang
Jan Stenvang currently works for Scandion Oncology.
Jan Stenvang's role at Scandion Oncology is CTO Scandion Oncology.
Jan Stenvang's email address is ***@scandiononcology.com. To view Jan Stenvang's full email address, please signup to ConnectPlex.
Jan Stenvang works in the Research industry.
Jan Stenvang's colleagues at Scandion Oncology are Haatisha Jandu, Jane Hinrichsen, Maj Hedtjärn, Johnny Stilou, Marc Bechmann, Peter Vestlev and others.
Jan Stenvang's phone number is N/A
See more information about Jan Stenvang